Evaluation of coagulopathies in acute promyelocytic leukemia at diagnosis and after complete remission by D-dimer titration

Authors

  • Mazen Khaddour Tishreen University
  • Rose Said Tishreen University

Abstract

Background: Early hemorrhagic deaths is the most important cause of fatality in acute promyelocytic leukemia. All trans retinoic acid has an important role to induce hematological remission and decrease the coagulopathies that accompanies acute promyelocytic leukemia.

Aim: to assess the efficacy of all trans retinoic acid on coagulation profile when complete hematological remission is achieved.

Materials and Methods: blood sample were collected from acute promyelocytic leukemia patients at diagnosis and at complete hematological remission.

Results: 25 patients were admission in Tishreen University hospital and were treated with all trans retinoic acid, idarubicin and supportive care to maintain a reasonable platelet count. 88% of patients achieved complete hematological remission. Two patients died during induction therapy due to intracranial hemorrhages. All trans retinoic acid was able to normalize coagulation parameters at remission with D-dimer being the most affected parameters of them all. This result emphasizes on the important of D-dimer titration to monitor the coagulopathies and treatment in acute promyelocytic leukemia.

Downloads

Published

2022-11-13

How to Cite

1.
خضور م, سعيد ر. Evaluation of coagulopathies in acute promyelocytic leukemia at diagnosis and after complete remission by D-dimer titration. Tuj-hlth [Internet]. 2022Nov.13 [cited 2024Nov.24];44(5):157-64. Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/13035

Issue

Vol. 44 No. 5 (2022): Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

Section

Master student researches

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.